Flurbiprofen

氟比洛芬

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameFlurbiprofen
Drug Alias NameAnsaid泽普思ZepolasBTS-188322
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsLow Back PainPainInflammation +[7] 
Global Approved IndicationsOsteoarthritisArthritis, Rheumatoid
Approved Indications in ChinaOsteoarthritis
Original Approved Country/TerritoryJapan
Original Approved Date1979/04/01
Country/TerritoryCanadaUnited StatesSwitzerland +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Mingze Zhonghe Pharmaceutical Research Co LtdPharmacia & Upjohn Company LlcCrookes Healthcare Ltd +[6] 
Inactive CompaniesPfizer Canada UlcReckitt Benckiser LlcTeikoku Pharma Usa Inc +[6] 
Active IndicationsPainInflammationOsteoarthritis +[4] 
Inactive IndicationsLow Back PainMouth DiseasesPharyngitis

Other Information

ATC CodeM01AE09M02AA19R02AX01 +[4] 
Related LinksWikipediaDrugBank